![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/c/c9/5-IT_Structure.svg/langzh-hans-640px-5-IT_Structure.svg.png&w=640&q=50)
5-(2-氨基丙基)吲哚
化合物 / 维基百科,自由的 encyclopedia
5-(2-氨基丙基)吲哚(5-API, 5-IT, PAL-571)[1]是一种具有移情作用的吲哚/苯乙胺衍生物,最初由艾伯特·霍夫曼于1962年报道。[2]它是一种狡诈家药物,自2011年以来,它以娱乐性用药在网上销售。[3]
Quick Facts 临床资料, 给药途径 ...
![]() | |
临床资料 | |
---|---|
给药途径 | 口服 |
ATC码 |
|
法律规范状态 | |
法律规范 |
|
识别信息 | |
| |
CAS号 | 3784-30-3 ![]() |
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard(英语:CompTox Chemicals Dashboard) (EPA) | |
ECHA InfoCard | 100.236.959 ![]() |
化学信息 | |
化学式 | C11H14N2 |
摩尔质量 | 174.25 g·mol−1 |
3D模型(JSmol(英语:JSmol)) | |
| |
|
Close
它是一种三元单胺释放剂(英语:Serotonin-norepinephrine-dopamine releasing agent),EC50值为12.9 nM(多巴胺)、13.3 nM(去甲肾上腺素)、104.8 nM(血清素),也是一种MAO-A抑制剂。[4][5]
参考文献
- Banks ML, Bauer CT, Blough BE, Rothman RB, Partilla JS, Baumann MH, Negus SS. Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys. Experimental and Clinical Psychopharmacology. June 2014, 22 (3): 274–284. PMC 4067459
. PMID 24796848. doi:10.1037/a0036595.
- FR 1344579,Hofmann, Albert; Troxler, Franz,“Nouveaux derives de l'indole et leur preparation”
- Katselou M, Papoutsis I, Nikolaou P, Spiliopoulou C, Athanaselis S. 5-(2-aminopropyl)indole: a new player in the drama of 'legal highs' alerts the community. Drug and Alcohol Review. January 2015, 34 (1): 51–7. PMID 24634984. doi:10.1111/dar.12136
.
- Marusich JA, Antonazzo KR, Blough BE, Brandt SD, Kavanagh PV, Partilla JS, Baumann MH. The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue. Neuropharmacology. February 2016, 101: 68–75. PMC 4681602
. PMID 26362361. doi:10.1016/j.neuropharm.2015.09.004.
- Herraiz T, Brandt SD. 5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO). Drug Testing and Analysis. July–August 2014, 6 (7–8): 607–13. PMID 24115740. doi:10.1002/dta.1530. hdl:10261/102667.